No profile data available.
Odyssey Therapeutics, Inc. (ODTX) is a listed company, based in Boston, United States, with about 100 full-time employees.
It reported revenue of $2.98 million for fiscal year 2025, down 33.5% from fiscal year 2024, and net income of -$148.65 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0, down 100.0% from a year before. Its market capitalization was $913.11 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.
Odyssey Therapeutics reported $2.98 million in revenue for fiscal year 2025, down 33.5% from $4.47 million in fiscal year 2024. In Q2 2026 revenue was $0.
$913.11 million as of October 9, 2026.